KDP categories · Top KDP authors
Maxine A. Papadakis: Amazon KDP author data
As of Nov 6, 2026, Maxine A. Papadakis has 5 books on Amazon, 5 of them on a best-seller list in the last 30 days (best rank #3), mostly in Pediatrics, Diagnosis, New, Used & Rental Textbooks.
| Median price | $79.65 |
|---|---|
| Price range (middle 50%) | $69.30 – $90 |
| Median reviews | 113 |
| Total reviews | 589 |
| New listings (30 days, incl. new editions) | 1 |
| Breakout books (30 days) | 1 |
What stands out
- 100% of the catalog made a best-seller list in the last 30 days: the whole backlist sells, not one hit.
- Median price $79.65, 41% above the median of their main category, Pediatrics.
Maxine A. Papadakis's best-ranked books
-
CURRENT Medical Diagnosis & Treatment 2027
by Maxine A. Papadakis
- Price$90
- Rating4.6
- Reviews13
- Published2026-09
-
CURRENT Medical Diagnosis and Treatment 2026
by Maxine A. Papadakis
- Price$69.30
- Rating4.6
- Reviews113
-
CURRENT Medical Diagnosis & Treatment 2026
by Maxine A. Papadakis
- Price$90
- Rating4.6
- Reviews113
-
CURRENT Medical Diagnosis and Treatment 2025
by Maxine A. Papadakis
- Price$69.30
- Rating4.8
- Reviews175
-
CURRENT Medical Diagnosis and Treatment 2025
by Maxine A. Papadakis
- Price-
- Rating4.8
- Reviews176
Main categories
FAQ
How many books does Maxine A. Papadakis have on Amazon?
KDPTop tracks 5 of their books; 5 made an Amazon list in the last 30 days.
Which categories does Maxine A. Papadakis publish in?
Their books chart most often in Pediatrics, Diagnosis, New, Used & Rental Textbooks.
How does Maxine A. Papadakis price their books?
The median price is $79.65; half of the books cost $69.30–$90.
Has Maxine A. Papadakis released new books recently?
1 new book in the last 30 days, 1 of which reached a Best Sellers list.
About this data
Data comes from KDPTop's daily crawl of Amazon's public Best Sellers pages; medians use the latest list. The opportunity score (0–100, higher is easier to enter) combines the review barrier, the share of low-review books, list turnover, new-release share and price.